{
  "docId": "019de076-9d2b-76a8-843e-6686f2efe993",
  "docSlug": "264dd70dbc5f8f6fdd2a3dbf6f8c09b5",
  "documentTitle": "Exscientia | Investor Day Presentation Deck | 90 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 90,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "roadmap",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide uses a horizontal bar chart structure to represent clinical development stages.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-9d2b-76a8-843e-6686f2efe993/10",
  "deckHref": "/decks/019de076-9d2b-76a8-843e-6686f2efe993",
  "deckJsonHref": "/decks/019de076-9d2b-76a8-843e-6686f2efe993.json",
  "deckAnchorHref": "/decks/019de076-9d2b-76a8-843e-6686f2efe993#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.33,
        "w": 0.3,
        "x": 0.2,
        "y": 0.33
      },
      "kind": "chart",
      "text": "Development status bars for GTAEXS617, EXS4318, EXS74539, EXS73565",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5202a422-3d62-4f5d-9bdd-3d6f27234f67",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.96,
        "x": 0.02,
        "y": 0.75
      },
      "kind": "paragraph",
      "text": "Multi-target collaborations with Sanofi, BMY & Merck KGaA; Broad internal focus on precision oncology; Additional clinical programmes through DSP collaboration",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8984e47d-b494-4e8c-a5fa-d479a656b7b9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.8,
        "x": 0.07,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "1) Phase 3 may not be required if Phase 2 is registrational; PKC-theta is in a Phase 1 healthy volunteer (HV) study; AML = acute myeloid leukaemia; SCLC = small-cell lung cancer",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2312e8db-c84f-4a5e-ad8f-6251bdef4abb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.96,
        "x": 0.02,
        "y": 0.24
      },
      "kind": "table",
      "text": "Programme, Target, Late Discovery, IND-Enabling, Phase 1/2, Phase 3/Approved, Indication, Exscientia Rights",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f05c7497-cd24-4485-8ca9-9587a74f89e1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.55,
        "x": 0.07,
        "y": 0.13
      },
      "kind": "title",
      "text": "Internal pipeline focused on high value oncology targets",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c51ebc84-d913-4083-857a-6de0767c95b6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.07,
        "y": 0.06
      },
      "kind": "title",
      "text": "Pipeline advancing to the clinic",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1112c353-ff34-4ea5-a201-0e94297068f7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "31188d31-11e8-4b4c-b5e8-ce24c9e9650c",
      "evidence": "The table uses horizontal bars to represent progress across clinical phases.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 10,
      "from": 4,
      "beatId": "6bcf15c0-6c27-4ba1-b4d0-3bb40c9a9b7c",
      "arcName": "AIDA",
      "arcSlug": "aida",
      "beatName": "Interest",
      "beatSlug": "aida-interest",
      "evidence": "The presentation deck generates interest by highlighting Exscientia's approach and achievements",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 4,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "118b0da0-1893-4824-ac01-9db0319b9704",
      "evidence": "The presentation deck presents a clear logic chain, connecting Exscientia's approach to its benefits",
      "position": 0,
      "objective": "To present Exscientia's approach to precision medicine",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}